Business activities

The Bioveta products are sold in 50 countries, both in Europe and in Asia, America and Africa - which ensures a certain grade of business and financial stability to the company

Bioveta, a. s. currently exports to these countries of the world:

• Algeria, Albania, Angola, Belorus, Bosnia, Brazil, Bulgaria, Columbia, Costa Rica, Croatia, Cuba, Cyprus, Denmark, Estonia, Ethiopia, Georgia, Germany, Ghana, Herzegovina, Honduras, Hungary, India, Indonesia, Iran, Italy, Israel, Japan, Jordan, Kenya, Latvia, Lebanon, Lithuania, Macedonia, Malaysia, Moldavia, Nepal, Nigeria, Pakistan, Peru, Poland, Russia, Romania, Saudi Arabia, Slovakia, Slovenia, Serbia, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Turkey, UAE, Ukraine, Uruguay, Vietnam, Zambia etc.

more ...

 

Bioveta, a.s. continues developing its sales activities and gradually increases its market shares in the sale of veterinary medicaments in these well-established territories. At the same time, the company makes a target-oriented marketing to acquire new interesting markets for certain groups of its products.

Bioveta considers it a significant success to have undergone a demanding inspection of the American authority USDA of Iowa in 2006 as the first Czech veterinary manufacturer. Thanks to this inspection, Bioveta prepares to export preparations to the United States of America.

At the beginning of 2006, Bioveta, a.s. successfully passed the audits held by the government authorities of Germany and South Korea and today, it exports selected products to these countries (Germany - vaccine against cattle trichophytosis, vaccine against Lyme disease in dogs, vaccine against plague and myxomatosis in rabbits; South Korea - dog vaccines).

The new sales activities of Bioveta, a. s. comprise the registration and sale of veterinary preparations in the USA (Biocan DHPPi), Denmark, Sweden, Bosnia, Saudi Arabia, UAE, Angola, Zambia, Lebanon, Honduras, Poland (hormones, vaccines), Malaysia (antibiotics), Tchaj-wan (diagnostics), India (dog vaccines), Costa Rica (diagnostics), Ghana (dog vaccines), Cyprus (dog vaccines, diagnostics, antiparasitics), Albania (poultry, pig and dog vaccines).

 

Bioveta, a. s. - share of sales on the Czech market and abroad

 With the 18% share Bioveta, a.s. occupies the leading position in the sales of veterinary production on the Czech market.

Bioveta a.s. occupies from 2 % to 16 % in the sale of veterinary.

 

 

Graph 1: Sale of veterinary products in 2012

 

Graph 2:  Sale of vaccines in 2012 according to target species

 

 

 

Graph 3: Export in 2012 according to countries